What possible risk/ benefit standard can justify giving an inadequately studied vaccine whose risks include serious, permanent adverse effects–including death– to millions of girls and women–who will likely never get cervical cancer? Continue reading →
Until now, American medicine as a profession has turned a blind eye and deaf ear to ghostwritten journal articles that have corrupted the integrity of the medical literature, displacing science-based medicine with corporate propaganda masquerading as science. Continue reading →
Two high ranking FDA officials’ conflicts of interest have led one to resign, the other is under investigation by the Inspector General of the Department of Health and Human Services:
Continue reading →
At the July 30, 2009 FDA advisory committee hearing, the only formal presentations at the meeting were a summary of the safety and efficacy data by the sponsor. Continue reading →
A system that was established to safeguard human subjects by implementing those ethical principles is, instead, geared toward lending the appearance of legitimacy to ethical expediency and corner-cutting at the expense of safety for the subjects of clinical trials and for consumers who are at increased risk of harm from defective drugs and devices.
Essentially PhRMA won the right to continue bilking the beleaguered American taxpayer–a concession won under the Bush Administration which prohibited Medicare to negotiate prescription drug prices.
Today’s New York Times reports (below) that "court documents provide a paper trail showing that Wyeth contracted with a medical communications company to outline articles, draft them and then solicit top physicians to sign their names, even though many of the doctors contributed little or no writing."